We are live on ! Find out more
CEP

Chicago Equity Partners Portfolio holdings

AUM $993M
1-Year Est. Return 6.42%
This Fund
S&P 500
This Quarter Est. Return
+4.19%
1 Year Est. Return
-6.42%
3 Year Est. Return
+34.83%
5 Year Est. Return
+90.28%
10 Year Est. Return
AUM
$3.74B
AUM Growth
+$30.1M
Cap. Flow
-$63.2M
Cap. Flow %
-1.69%
Top 10 Hldgs %
20.81%
Holding
522
New
133
Increased
134
Reduced
181
Closed
67

Top Buys

Rank Stock Value
1
CME icon
CME Group
CME
+$34.2M
2
JBL icon
Jabil
JBL
+$28.4M
3
CSCO icon
Cisco
CSCO
+$25.9M
4
SHW icon
Sherwin-Williams
SHW
+$22.5M
5
AAPL icon
Apple
AAPL
+$20.8M

Sector Composition

Rank Sector Weight
1 Financials 15.51%
2 Technology 14.95%
3 Healthcare 14.75%
4 Industrials 11.9%
5 Communication Services 8.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CAH icon
51
Cardinal Health
CAH
$53.4B
$24.8M 0.66%
274,680
-17,850
-6% -$1.54M
PSA icon
52
Public Storage
PSA
$60.2B
$24.5M 0.66%
124,525
-3,410
-3% -$675K
MRK icon
53
Merck
MRK
$324B
$24.5M 0.65%
446,097
+273,429
+158% +$15.5M
ABBV icon
54
AbbVie
ABBV
$458B
$23.8M 0.63%
406,080
+127,450
+46% +$7.7M
EW icon
55
Edwards Lifesciences
EW
$47.6B
$23.7M 0.63%
997,020
+17,880
+2% +$401K
ATO icon
56
Atmos Energy
ATO
$29.9B
$23.6M 0.63%
426,230
+174,730
+69% +$9.61M
LOW icon
57
Lowe's Companies
LOW
$116B
$23.5M 0.63%
315,535
-1,675
-0.5% -$120K
HON icon
58
Honeywell
HON
$77.1B
$23.2M 0.62%
247,758
+91,741
+59% +$8.4M
UTHR icon
59
United Therapeutics
UTHR
$26.3B
$23.1M 0.62%
133,905
-2,510
-2% -$383K
SLB icon
60
SLB Ltd
SLB
$77.8B
$22.2M 0.59%
266,164
+233,694
+720% +$19.5M
CVX icon
61
Chevron
CVX
$388B
$21.2M 0.57%
202,305
-5,160
-2% -$551K
PM icon
62
Philip Morris
PM
$301B
$20.7M 0.55%
274,650
-5,175
-2% -$420K
CVC
63
DELISTED
CABLEVISION SYS CP NY GRP CL-A
CVC
$20.4M 0.54%
1,114,944
-436,201
-28% -$8.36M
COST icon
64
Costco
COST
$415B
$20.3M 0.54%
133,680
+25,960
+24% +$3.81M
TGT icon
65
Target
TGT
$62.1B
$19.6M 0.52%
+238,470
New +$18.4M
MHFI
66
DELISTED
MCGRAW-HILL FINANCIAL INC COM
MHFI
$19.5M 0.52%
188,555
+28,420
+18% +$2.79M
MMM icon
67
3M
MMM
$89B
$19.4M 0.52%
140,853
+1,393
+1% +$192K
MNK
68
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$19.2M 0.51%
151,749
+95,910
+172% +$11M
TXN icon
69
Texas Instruments
TXN
$255B
$18.9M 0.51%
330,830
+278,855
+537% +$15.7M
ASH icon
70
Ashland
ASH
$3.04B
$18.6M 0.5%
298,588
+287,612
+2,620% +$17.4M
CBL
71
DELISTED
CBL& Associates Properties, Inc.
CBL
$18.5M 0.49%
932,880
+356,420
+62% +$7.18M
DAL icon
72
Delta Air Lines
DAL
$55.9B
$18.3M 0.49%
407,160
-160,760
-28% -$7.46M
EXC icon
73
Exelon
EXC
$48.6B
$17.9M 0.48%
748,486
-128,374
-15% -$3.18M
CDW icon
74
CDW
CDW
$17.1B
$17.9M 0.48%
+480,205
New +$17.5M
PPC icon
75
Pilgrim's Pride
PPC
$6.82B
$17.8M 0.48%
787,385
+10,650
+1% +$303K

Similar funds

Chicago Equity Partners's Q1 2015 Portfolio in Review

As of Q1 2015, Chicago Equity Partners held 522 positions worth $3.74B, up 0.81% from $3.71B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Chicago Equity Partners's Q1 2015 filing shows 133 new, 134 increased, 181 reduced and 67 closed positions. Its largest new stake was CME Group: 368,700 shares worth $34.9M. The largest sale was Pfizer, an estimated $33.3M.

By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 16% a quarter earlier, followed by Technology and Healthcare.

  • Chicago Equity Partners's largest Q1 2015 buy was CME Group: 368,700 shares worth $34.9M.
  • Chicago Equity Partners added most to Jabil in Q1 2015, an estimated $28.4M increase.
  • Chicago Equity Partners's biggest Q1 2015 reduction was Pfizer, cutting an estimated $33.3M.
  • Chicago Equity Partners fully exited COVIDIEN PLC COM SHS NEW (IRELAND) in Q1 2015, selling an estimated $21.8M.
  • Chicago Equity Partners's ten largest holdings make up 21% of its $3.74B portfolio in Q1 2015.
  • Chicago Equity Partners opened 133 new positions and closed 67 in Q1 2015.
  • Chicago Equity Partners's portfolio value rose 0.81% quarter-over-quarter to $3.74B.

Based on Chicago Equity Partners's 13F filing for Q1 2015, filed 1 May 2015.